Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Other Non-Current Assets (2016 - 2025)

Lipocine's Other Non-Current Assets history spans 13 years, with the latest figure at $23753.0 for Q3 2025.

  • For Q3 2025, Other Non-Current Assets changed 0.0% year-over-year to $23753.0; the TTM value through Sep 2025 reached $23753.0, changed 0.0%, while the annual FY2024 figure was $23753.0, 0.0% changed from the prior year.
  • Other Non-Current Assets reached $23753.0 in Q3 2025 per LPCN's latest filing, roughly flat from $23753.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $23753.0 in Q1 2021 to a low of $23753.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $23753.0, with a median of $23753.0 recorded in 2021.
  • The largest YoY upside for Other Non-Current Assets was 0.0% in 2021 against a maximum downside of 99.52% in 2021.
  • A 5-year view of Other Non-Current Assets shows it stood at $23753.0 in 2021, then changed by 0.0% to $23753.0 in 2022, then changed by 0.0% to $23753.0 in 2023, then changed by 0.0% to $23753.0 in 2024, then changed by 0.0% to $23753.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Other Non-Current Assets are $23753.0 (Q3 2025), $23753.0 (Q2 2025), and $23753.0 (Q1 2025).